APA
Eggermont A. M. M., Blank C. U., Mandala M., Long G. V., Atkinson V., Dalle S., Haydon A., Lichinitser M., Khattak A., Carlino M. S., Sandhu S., Larkin J., Puig S., Ascierto P. A., Rutkowski P., Schadendorf D., Koornstra R., Hernandez-Aya L., Maio M., van den Eertwegh A. J. M., Grob J., Gutzmer R., Jamal R., Lorigan P., Ibrahim N., Marreaud S., van Akkooi A. C. J., Suciu S. & Robert C. (20180517). Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma. : The New England journal of medicine.
Chicago
Eggermont Alexander M M, Blank Christian U, Mandala Mario, Long Georgina V, Atkinson Victoria, Dalle Stéphane, Haydon Andrew, Lichinitser Mikhail, Khattak Adnan, Carlino Matteo S, Sandhu Shahneen, Larkin James, Puig Susana, Ascierto Paolo A, Rutkowski Piotr, Schadendorf Dirk, Koornstra Rutger, Hernandez-Aya Leonel, Maio Michele, van den Eertwegh Alfonsus J M, Grob Jean-Jacques, Gutzmer Ralf, Jamal Rahima, Lorigan Paul, Ibrahim Nageatte, Marreaud Sandrine, van Akkooi Alexander C J, Suciu Stefan and Robert Caroline. 20180517. Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma. : The New England journal of medicine.
Harvard
Eggermont A. M. M., Blank C. U., Mandala M., Long G. V., Atkinson V., Dalle S., Haydon A., Lichinitser M., Khattak A., Carlino M. S., Sandhu S., Larkin J., Puig S., Ascierto P. A., Rutkowski P., Schadendorf D., Koornstra R., Hernandez-Aya L., Maio M., van den Eertwegh A. J. M., Grob J., Gutzmer R., Jamal R., Lorigan P., Ibrahim N., Marreaud S., van Akkooi A. C. J., Suciu S. and Robert C. (20180517). Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma. : The New England journal of medicine.
MLA
Eggermont Alexander M M, Blank Christian U, Mandala Mario, Long Georgina V, Atkinson Victoria, Dalle Stéphane, Haydon Andrew, Lichinitser Mikhail, Khattak Adnan, Carlino Matteo S, Sandhu Shahneen, Larkin James, Puig Susana, Ascierto Paolo A, Rutkowski Piotr, Schadendorf Dirk, Koornstra Rutger, Hernandez-Aya Leonel, Maio Michele, van den Eertwegh Alfonsus J M, Grob Jean-Jacques, Gutzmer Ralf, Jamal Rahima, Lorigan Paul, Ibrahim Nageatte, Marreaud Sandrine, van Akkooi Alexander C J, Suciu Stefan and Robert Caroline. Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma. : The New England journal of medicine. 20180517.